Celldex Therapeutics | CLDX - Equity Capital And Reserves

Stock Price
23.55
Daily Change
-0.72 -2.97%
Monthly
-8.01%
Yearly
-1.83%
Q1 Forecast
23.84

Celldex Therapeutics reported $598.36M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Celldex Therapeutics USD 598.36M 57.04M Sep/2025
Glaxosmithkline GBP 21.7B 7.35B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025